Lymphatic Filariasis
Cross-source consensus on Lymphatic Filariasis from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Dosage & preparation
Background
Highlighted claims
- The global LF elimination strategy relies on mass drug administration and morbidity management with disability prevention. — Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol
- Lymphatic filariasis elimination remains targeted globally for 2030 after the earlier 2020 target was shifted. — Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol
- WHO defines effective MDA coverage as at least 65% per round, aiming to reduce microfilaria prevalence below 1%. — Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol
- India’s LF elimination programme still had 159 districts across 13 states implementing MDA as of 2024. — Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol